Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
121.50    -0.50 (-0.41%)
Bid:
120.00
Ask:
122.00
Spread: 2.00 (1.667%)
Market Cap: £95.35m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Period end trading update

21 Jan 2010 07:00

RNS Number : 8908F
Xaar PLC
21 January 2010
 



FOR IMMEDIATE RELEASE

21 January 2010

Xaar plc

FULL YEAR TRADING UPDATE

Xaar plc ("Xaar"), the inkjet printing technology group headquartered in Cambridge, presents an update on trading performance for the year ended 31 December 2009.

Trading

Trading for the fourth quarter of 2009 and the year as a whole was in line with the Board's expectations and the financial results for the 12 months ended 31 December 2009 are expected to be in line with market expectations.

The trends reported in the IMS dated 14 October 2009 continued through to the year-end. OEM customers are continuing to develop digital printing machines incorporating Xaar's Platform 3 technology and, whilst some applications are now technically proven and contribute material revenue to Xaar, others still remain some way from full commercialisation. Xaar remains committed to providing its Platform 3 customers with the necessary support to bring these developments to a successful conclusion and has continued to incur some significant costs in doing this.

Sales of Platform 1 products continue to deliver the majority of Xaar's revenues through both new product launches and continuing sales of existing products, albeit at lower margins than seen historically. These lower margins are a direct result of the highly competitive nature of this market and, as is the case for Platform 3, higher than expected customer support costs for some of these products.

The project to transfer those manufacturing facilities located in Sweden to the Group's Huntingdon facility continues to be on track with completion scheduled for March 2011.

Whilst results for 2009 are expected to be in line with market consensus, the level of profitability reflected the benefits of the cost cutting programme previously implemented offset by the higher than anticipated product and customer support costs. The Board is continuing to take appropriate action to improve profitability and is planning on delivering improved results for 2010.

Cash

Net cash and cash equivalents at 31 December 2009 were approximately £11.1m (31 December 2008: £11.0m, 30 June 2009: £10.3m) after payment of £1.5dividends in the year.

Dividend

It is the Board's intention to recommend the payment of a final dividend, details of which will be provided at the time of the announcement of the final results for the year.

Announcement of final results

The detailed results for 2009 will be announced in accordance with Xaar's normal timetable on 17 March 2010.

Ends

CONTACTS

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Andrew Taylor, Finance Director 

 

 

 

Singer Capital Markets Limited:

020-3205-7626

Shaun Dobson

 

 

 

Bankside Consultants:

 

Steve Liebmann

020-7367-8883 / 07802-888159

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSEFEFSFSSEEF
Date   Source Headline
21st Sep 20239:57 amRNSHolding(s) in Company
19th Sep 20237:00 amRNS2023 Interim Results
11th Sep 20232:11 pmRNSHolding(s) in Company
11th Sep 202312:14 pmRNSHolding(s) in Company
11th Sep 202312:07 pmRNSHolding(s) in Company
11th Sep 202312:03 pmRNSHolding(s) in Company
11th Sep 202312:02 pmRNSHolding(s) in Company
11th Sep 202312:02 pmRNSHolding(s) in Company
7th Sep 20239:00 amRNSNotice of 2023 Half Year Results
1st Sep 20239:30 amRNSTotal Voting Rights
25th Aug 202312:13 pmRNSHolding(s) in Company
23rd Aug 202310:24 amRNSHolding(s) in Company
18th Aug 202310:30 amRNSChange of Auditor
17th Aug 202312:55 pmRNSHolding(s) in Company
3rd Aug 20237:00 amRNSTrading Update
1st Aug 20232:00 pmRNSTotal Voting Rights
28th Jul 20234:30 pmRNSHolding(s) in Company
5th Jul 20239:00 amRNSXaar plc - Commercial partnership with Quantica
4th Jul 20233:00 pmRNSBlock listing Interim Review
3rd Jul 20232:53 pmRNSTotal Voting Rights
1st Jun 202310:37 amRNSTotal Voting Rights
31st May 202311:30 amRNSResult of AGM
31st May 20239:00 amRNSBoard Changes
11th May 20235:41 pmRNSHolding(s) in Company
10th May 20233:10 pmRNSDirector/PDMR Shareholding
2nd May 202312:39 pmRNSTotal Voting Rights
24th Apr 20231:05 pmRNSAnnual Financial Report
3rd Apr 20234:51 pmRNSTotal Voting Rights
28th Mar 20237:00 amRNSFinal Results
20th Mar 20232:00 pmRNSNotification of the 2022 Full Year Results Date
1st Mar 20233:19 pmRNSTotal Voting Rights
20th Feb 202312:35 pmRNSHolding(s) in Company
1st Feb 202312:30 pmRNSTotal Voting Rights
30th Jan 202312:30 pmRNSHolding(s) in Company
12th Jan 20237:00 amRNSTrading Update
5th Dec 202210:21 amRNSDirector/PDMR Shareholding
1st Dec 202210:19 amRNSTotal Voting Rights
21st Nov 20224:41 pmRNSSecond Price Monitoring Extn
21st Nov 20224:35 pmRNSPrice Monitoring Extension
3rd Nov 20221:38 pmRNSGrant of Sharesave Options
1st Nov 202210:41 amRNSTotal Voting Rights
13th Oct 20222:20 pmRNSHolding(s) in Company
3rd Oct 20224:07 pmRNSTotal Voting Rights
20th Sep 20227:00 amRNS2022 INTERIM RESULTS
1st Sep 20225:32 pmRNSTotal Voting Rights
30th Aug 202210:26 amRNSNotice of 2022 Half Year Results
1st Aug 20224:33 pmRNSTotal Voting Rights
1st Aug 202211:25 amRNSHolding(s) in Company
14th Jul 20227:00 amRNSTrading Update
1st Jul 20221:14 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.